Hipolin Peer Comparison

BSE: 530853

₹94.45

₹-4.95 (-4.98%)

As on 28-Aug-2026IST

Market cap

₹30 Cr

Revenue (TTM)

₹16 Cr

P/E Ratio

758.3

P/B Ratio

4

Div. Yield

0 %

Edit

	Hipolin	Pee Cee Cosma Sope	Cupid	Gillette India	Zydus Wellness
Market cap (₹ Cr)	30	113	37,987	23,880	16,737
Revenue (₹ Cr)	16	167	455	3,176	4,537
Net Profit (₹ Cr)	0.04	8.67	137.38	668.07	188.20
Net Margin (%)	0.26	5.16	28.40	20.86	4.14
RoE (%)	-0.13	15.90	33.02	63.35	3.99
Price to Earnings	758.34	13.07	276.52	35.75	88.93
Price-To-Book	3.99	--	76.81	21.90	2.82

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement (₹ Cr)

	Hipolin	Pee Cee Cosma Sope	Cupid	Gillette India	Zydus Wellness
Operating Revenue	21.56	140.59	183.52	2,633.08	2,708.90
Total Income	21.93	142.33	203.18	2,659.18	2,723.30
Total Expenditure	24.86	127.57	141.80	2,001.68	2,330.00
EBITDA	-3.29	13.02	41.73	631.40	378.90
Depreciation	0.09	1.63	4.48	82.64	28.40
EBIT	-3.39	11.38	37.25	548.76	350.50
Interest	0.26	0.22	2.05	12.61	12.00
Other Income	0.37	1.74	19.66	26.10	14.40
Exceptional Items	--	--	--	--	5.90
Profit before Tax	-3.28	12.91	54.86	562.25	358.80
Provision for Tax	--	3.30	13.97	150.55	11.90
Profit after Tax	-3.28	9.61	40.89	411.70	346.90

Liabilities (₹ Cr)

	Hipolin	Pee Cee Cosma Sope	Cupid	Gillette India	Zydus Wellness
Shareholder's Funds	8.14	48.57	342.19	971.27	5,671.60
Minority Interest	--	--	--	--	--
Non-Current Liabilities	0.74	0.36	8.39	46.97	-119.90
Current Liabilities	4.09	8.45	21.20	759.04	745.50
Total Liabilities	12.98	57.71	371.78	1,830.75	6,441.90

Assets (₹ Cr)

	Hipolin	Pee Cee Cosma Sope	Cupid	Gillette India	Zydus Wellness
Non-Current Assets	8.33	29.58	89.90	590.67	5,193.00
Current Assets	4.65	27.81	281.88	1,186.61	1,104.20
Total Assets	12.98	57.71	371.78	1,830.75	6,441.90
Total Debt*	2.87	1.15	12.63	0.00	185.00
Net Current Assets	0.56	19.36	260.68	427.57	358.70
Contingent Liabilities	--	0.15	6.37	1,408.05	351.30

Cashflow (₹ Cr)

	Hipolin	Pee Cee Cosma Sope	Cupid	Gillette India	Zydus Wellness
Cash From Operating Activities	-3.18	7.31	-11.14	509.04	380.00
Cash Flow from Investing Activities	2.76	-5.88	44.68	-49.15	-223.60
Cash from Financing Activities	0.54	-1.44	-1.47	-439.90	-186.30
Net Cash Inflow / Outflow	0.12	0.00	32.08	19.99	-29.90

Ratios

Profitability Ratios

	Hipolin	Pee Cee Cosma Sope	Cupid	Gillette India	Zydus Wellness
ROCE (%)	-24.62	28.85	17.04	58.66	6.43
ROE (%)	-33.51	21.63	18.25	42.92	6.29
ROA (%)	-22.41	18.26	11.82	22.57	5.65
EBIT Margin (%)	-13.55	10.50	33.45	24.97	14.52
Net Margin (%)	-14.94	6.75	20.12	15.48	12.74
Cash Profit Margin (%)	-14.76	8.00	24.72	15.42	12.78

Growth Ratios

	Hipolin	Pee Cee Cosma Sope	Cupid	Gillette India	Zydus Wellness
Revenue Growth (%)	9.29	5.20	6.88	6.30	16.37
EBIT Growth (%)	-314.49	-7.52	7.10	17.13	22.10
Net Profit Growth (%)	-269.88	-7.99	2.59	15.75	29.97
EPS Growth (%)	-268.71	-7.99	925.59	15.75	29.97
Book Value Growth (%)	-28.70	20.57	19.40	-2.18	5.86

Valuation Ratios

	Hipolin	Pee Cee Cosma Sope	Cupid	Gillette India	Zydus Wellness
Price / Earnings	0.00	14.65	8.32	57.34	6.13
Price / Book Value	3.33	2.90	6.97	24.88	1.87
Dividend Yield (%)	0.00	0.56	0.00	1.79	0.36
EV/EBITDA	-10.15	9.60	26.79	35.18	27.31
Market Cap (₹ Cr)	27.09	140.79	1,700.47	23,607.67	10,631.08

Solvency Ratios

	Hipolin	Pee Cee Cosma Sope	Cupid	Gillette India	Zydus Wellness
Debt to Equity	0.35	0.02	0.05	0.00	0.03
Short term debt to equity ratio	0.26	0.02	0.04	--	0.03
Current Ratio	1.14	3.29	13.30	1.56	1.48
Quick Ratio	0.82	1.24	11.33	1.04	0.79
Interest Coverage	-11.60	60.07	27.74	45.59	30.90

Operating Efficiency Ratios

	Hipolin	Pee Cee Cosma Sope	Cupid	Gillette India	Zydus Wellness
Debtors to sales (%)	14.07	0.44	36.53	10.42	13.55
Asset Turnover	1.47	2.67	0.53	1.76	0.48
Receivable days	56.05	1.27	114.37	33.84	40.43
Inventory Days	21.37	40.36	57.01	46.00	61.24
Payable days	54.31	12.63	6.27	218.60	113.05
Cash Conversion Cycle	23.11	29.00	165.11	-138.76	-11.38

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.